ISRVF:OTC-iShares Public Limited Company - iShares MSCI Japan USD Hedged UCITS ETF (Acc) (USD)

ETF | Others |

Last Closing

USD 71.846

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.98K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

-0.94 (-0.17%)

USD 32.85B
IISHF iShares III Public Limited Com..

N/A

USD 9.10B
ZKBGF ZKB Gold ETF

N/A

USD 8.96B
IHPCF iShares Public Limited Company..

+0.43 (+0.82%)

USD 8.93B
CUYTY Etablissementen Franz Colruyt ..

+0.17 (+1.45%)

USD 7.56B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
PHBBF Pharmaron Beijing Co., Ltd.

N/A

USD 6.70B
BCYIF iShares Public Limited Company..

N/A

USD 5.80B
IIREF iShares Public Limited Company..

N/A

USD 5.32B
IHSXF iShares Public Limited Company..

-0.34 (-0.35%)

USD 4.14B

ETFs Containing ISRVF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.31% 92% A 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.31% 92% A 77% C+
Trailing 12 Months  
Capital Gain 41.03% 92% A 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.03% 92% A 85% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 16.00% 84% B 63% D
Dividend Return 16.00% 84% B 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.65% 56% F 92% A
Risk Adjusted Return 102.27% 100% F 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike